- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Results
14
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
14 companies
Lytix Biopharma
Market Cap: NOK 341.3m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 5.00
7D
2.5%
1Y
-12.3%
PCI Biotech Holding
Market Cap: NOK 49.6m
A biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform.
PCIB
NOK 1.33
7D
7.7%
1Y
-26.7%
Thor Medical
Market Cap: NOK 756.2m
Produces and supplies alpha-particle emitters for cancer therapy in Norway.
TRMED
NOK 2.41
7D
6.9%
1Y
133.9%
ArcticZymes Technologies
Market Cap: NOK 868.2m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, rest of Europe, the United States, and internationally.
AZT
NOK 17.00
7D
10.0%
1Y
-39.3%
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide.
VISTN
NOK 23.20
7D
0.9%
1Y
0.9%
Oncoinvent
Market Cap: NOK 117.9m
A clinical stage company, develops products to treat cancer patients.
ONCIN
NOK 1.21
7D
-16.1%
1Y
n/a
Nykode Therapeutics
Market Cap: NOK 724.9m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 2.22
7D
5.6%
1Y
-83.0%
Photocure
Market Cap: NOK 1.4b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the BeNeLux, Italy, other European Countries, Canada, and the United States.
PHO
NOK 51.90
7D
2.4%
1Y
-7.2%
EXACT Therapeutics
Market Cap: NOK 193.6m
A clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT).
EXTX
NOK 3.06
7D
2.0%
1Y
-56.3%
SoftOx Solutions
Market Cap: NOK 131.7m
Operates as a medtech and clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway.
SOFTX
NOK 0.059
7D
20.5%
1Y
-76.1%
BerGenBio
Market Cap: NOK 68.0m
A clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway.
BGBIO
NOK 1.70
7D
9.7%
1Y
-89.8%
Zelluna
Market Cap: NOK 258.9m
Develops T-cell receptor (TCR) cellular immunotherapy products for the treatment of solid cancers.
ZLNA
NOK 12.80
7D
-5.2%
1Y
n/a
Arctic Bioscience
Market Cap: NOK 138.8m
A clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds.
ABS
NOK 5.20
7D
30.0%
1Y
-50.0%
Navamedic
Market Cap: NOK 330.3m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 18.70
7D
2.7%
1Y
-44.3%